Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

KYTH 39.28 -0.41 (-1.03%)
price chart
Kythera Biopharmaceuticals, Inc. Price Target Update
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH): The mean estimate for the short term price target for Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) stands at $56.25 according to 4 Analysts. But, the investors should remain cautious as the stock may ...
KYTHERA Biopharmaceuticals Announces 2014 Operating Results  GlobeNewswire (press release)
Insider Selling: Nathaniel E. David Sells 1875 Shares of Kythera ...  Dakota Financial News
Kythera Biopharmaceuticals Inc. (KYTH) is Trading Lower on Unusual Volume ...
Kythera Biopharmaceuticals Inc. ($KYTH) experienced unusually high volume on Mar. 02, as the stock lost 2.89% to a closing price of $40.35.
KYTHERA Biopharmaceuticals Appoints Hollings C. Renton to Board of Directors
WESTLAKE VILLAGE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that it has named Hollings C. Renton to its Board of Directors.
Related articles »  
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
KYTHERA Biopharmaceuticals, Inc. KYTH, +1.84% today announced that on January 30, 2015, the Compensation Committee of the Company's Board of Directors granted five new employees options to purchase an aggregate of 52,500 shares of the ...
Kythera Biopharmaceuticals Inc Registers High Short Percent of Float  Wall Street Pulse
Short Interest of Kythera Biopharmaceuticals Inc Drops by 0.2%
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) reported a drop of 0.2% or 9,314 shares in its short interest. The short figure came in at 28.7% of the total floats.
Kythera Biopharmaceuticals Inc. (KYTH) is Trading Higher on Unusual Volume ...
Kythera Biopharmaceuticals Inc. ($KYTH) experienced unusually high volume on Feb. 26, as the stock gained 1.84% to a closing price of $43.24.
Kythera Biopharmaceuticals Inc Short Interest Update
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), A rise of 77,491 shares or 1.6% was seen in the short interest of Kythera Biopharmaceuticals, Inc.. Even as the interest increased from 5,009,405 shares on January 30,2015 to 5,086,896 shares on February ...
Kythera Biopharmaceuticals Inc Insider Trading Update
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the CFO of KYTHERA Biopharmaceuticals Inc, Smither John W had sold 2,000 shares worth of $82,000 ...
Large Inflow of Money Witnessed in Kythera Biopharmaceuticals Inc  Stafford Daily
Kythera Biopharmaceuticals Inc Analyst Rating Update  Bar and Graph Report
Share Price of Kythera Biopharmaceuticals, Inc. Drops by -4.33%
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) has dropped 4.33% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 11.69% in the last 4 weeks.
KYTHERA Biopharmaceuticals to Present at the 2015 Leerink Global Healthcare ...
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market.
KYTHERA Biopharmaceuticals Submits Drug Application in Australia for Novel ...  CNNMoney